Dr. Morgan Allyn Sendzischew Shane, MD

Dr. Sendzischew Shane practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Sendzischew Shane's NPI, 1124384029, was assigned on April 4, 2012. Dr. Sendzischew Shane graduated from University of Miami, Miller School of Medicine in 2012. Dr. Sendzischew Shane holds Florida license ME124721.

Dr. Sendzischew Shane's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Sendzischew Shane's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Sendzischew Shane is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Sendzischew Shane to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sendzischew Shane practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Sendzischew Shane's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Sendzischew Shane is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Sendzischew Shane is licensed in Florida.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, colonoscopy, gastroduodenitis, gastroenteritis, hemorrhoids and intestinal diverticulosis among the conditions Dr. Sendzischew Shane treats.

CMS data shows 280 Medicare services from Dr. Sendzischew Shane across 11 procedure codes in 2024, for 250 Medicare patients. Medicare paid $28,914 for them.

CMS counts 250 Medicare patients who saw Dr. Sendzischew Shane in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sendzischew Shane's median patient age at 68, with 71% women.

In 2024, Dr. Sendzischew Shane wrote 578 Medicare Part D claims for 156 patients. 73% of them were for generic drugs. CMS names the drug for 434 of them, across 14 drugs with 11 or more claims each, at $175,909 in total drug cost. In 2023, CMS named 368 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Sendzischew Shane for performance year 2024, reported as part of a group. Dr. Sendzischew Shane accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sendzischew Shane as offering telehealth. CMS counts 60 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Sendzischew Shane, more than 66% of the clinicians it reports for that procedure.

CMS Open Payments shows 48 general payments to Dr. Sendzischew Shane from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Medtronic, Inc. paid the most, $417.

Dr. Sendzischew Shane graduated from University of Miami, Miller School of Medicine in 2012.

Dr. Sendzischew Shane is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.